Follow-up of children with autoimmune hepatitis treated with cyclosporine

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 5, 2006, Pages 635-639

  Cuarterolo, Miriam ^a   Ciocca, Mirta ^a   Velasco, Cristina Cañero ^b   Ramonet, Margarita ^c   González, Teresita ^d   López, Susana ^a   Garsd, Armando ^e   Álvarez, Fernando ^f  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b Hospital de Ninos de San Justo   (Argentina)

^c HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^d Hospital de Ninos Sor Maria Ludovica   (Argentina)

^e Hollis Eden Pharmaceuticals Inc   (United States)

^f UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Autoimmune hepatitis; Cyclosporine; Prognosis; Treatment

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CYCLOSPORIN A; PREDNISONE;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CHILD; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; GINGIVA HYPERTROPHY; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RELAPSE; REMISSION; SIDE EFFECT;

EID: 33845272531     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000235975.75120.38     Document Type: Article

References (16)

1. Johnson PJ, McFarlane IG. Meeting Report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
2. Maggiore G, Bernard O, Hadchouel M, et al. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr 1984;104:839-44.
3. Maggiore G, Bernard O, Homberg J, et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 1986;108:399-404.
4. Maggiore G, Porta G, Bernard O, et al. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr 1990;116:280-2.
5. Maggiore G, Veber F, Bernard O, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993;17:376-81.
6. Gregorio G, Portmann B, Reid F, et al. Autoimmune hepatitis: 20 years of experience. Hepatology 1997;25:541-7.
7. Czaja AJ. Diagnosis, prognosis and treatment of classical autoimmune chronic active hepatitis. In: Autoimmune Liver Diseases. Edited by Krawitt EL, Wiesner RH. New York, NY: Raven Press; 1991: pp. 143-66.
8. Álvarez F, Ciocca M, Cañero-Velasco C, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999;30:222-7.
9. Álvarez F, Berg P, Bianchi F, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
10. Desmet V, Gerber M, Hoofnagle J, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
11. Cantor A. Extending SAS survival analysis techniques for medical research. Cary, NC: SAS Institute Inc, 1997:208.
12. Lee ET. Statistical Methods for Survival Data Analysis. New York: John Wiley & Sons Inc, 1992:250-262.
13. SAS/STAT User's Guide, Version 8.2. Cary, NC: SAS Institutes Inc.
14. Debray D, Maggiore G, Girardet J, et al. Efficacy of cyclosporine A in children with type 2 autoimmune hepatitis. J Pediatr 1999;135:111-4.
15. Paradis K, El Edreesi M, St-Vil D, et al. Cyclosporine kinetics in pediatric liver transplant recipients: impact of dose fractionation on true glomerular filtration rate. Transplant Proc 1994;26:2777-8.
16. Malekzadeh R, Nasseri-Moghaddam S, Kaviani M, et al. Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001;46:1321-7.